Tetrazolast
Alternative Names: MDL 26024GOLatest Information Update: 08 Jul 2002
At a glance
- Originator Aventis
- Class Antiallergics; Antiasthmatics
- Mechanism of Action Histamine release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 22 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma
- 21 Apr 1995 A clinical study has been added to the Asthma pharmacodynamics section